EuroSIDA Publications 2020

1 Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting. Greenberg L, Ryom L, Wandeler G, Grabmeier-Pfistershammer K, Öllinger A, Neesgaard B, Stephan C, Calmy A, Rauch A, Castagna A, Spagnuolo V, Johnson M, Stingone C, Mussini C, De Wit S, Necsoi C, Campins AA, Pradier C, Stecher M, Wasmuth JC, Monforte AD, Law M, Puhr R, Chkhartishvilli N, Tsertsvadze T, Garges H, Thorpe D, Lundgren JD, Peters L, Bansi-Matharu L, Mocroft A; RESPOND Study Group.
J Acquir Immune Defic Syndr. 2020;83(3):240-250. Abstract

2 Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment
Mocroft A, Lundgren J, Gerstoft J, Rasmussen LD, Bhagani S, Aho I, Pradier C, Bogner JR, Mussini C, Uberti Foppa C, Maltez F, Laguno M, Wandeler G, Falconer K, Trofimova T, Borodulina E, Jevtovic D, Bakowska E, Kase K, Kyselyova G, Haubrich R, Rockstroh JK, Peters L; EuroSIDA Study.
Clin Infect Dis. 2020;70(10):2131-2140. Abstract

3 Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment. Mocroft, A, and RESPOND study group.
HIV Med. 2020. Abstract

4 Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons. A Mocroft, L Ryom, C Oprea, Q Li, A Rauch, C Boesecke, V Uzdaviniene, D Sedlacek, JM. Llibre, K Lacombe,  LN. Nielsen,  Florence, I Aho, N Chkhartishvili, J Szlavik, G Dragovic, C Leen, H Sambatakou, T Staub, M Laguno, H Elinav, J Tomazic, L Peters, for the EuroSIDA study group.
AIDS. 2020;34(10):1485-1495. Abstract

5 How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium. B Neesgaard *, A Mocroft, L Greenberg, JF Larsen, G Wandeler, R Zangerle, H Günthard, C Smith, S De Wit, C Mussini, A Castagna, a D'Arminio Monforte, JJ Vehreschild, JC Wasmuth, C Pradier, N Chkhartishvili, F W.N.M. Wit, M Law, A Sönnerborg, A Bruguera, C Stephan, V Vannappagari, R Haubrich, O Kirk, D Podlekareva, J Kowalska, D Raben, J Rockstroh, L Peters, R Parades, K Grabmeier-Pfistershammer, A Scherrer, M Johnson, C Necsoi, V Borghi, C Muccini, T Tserstvadze, K Petoumenos, A Volny-Anne, J Lundgren, L Ryom, for the RESPOND study group
Microorganisms. 2020;8(8):E1164. Abstract

6 Influence of Hepatitis C coinfection and treatment on risk of diabetes mellitus in HIV-positive persons A Mocroft, JD Lundgren, J Rockstroh, I Aho, G Wandeler, L Nielsen, S Edwards, J Viard, K Lacombe, G Fätkenheuer, G Guaraldi, M Laguno, J Llibre, H Elinav, L Flamholc, M Gisinger, D Paduta, I Khromova, D Jilich, B Rozplochowski, C Oprea, L Peters on behalf of the EuroSIDA study
Open Forum Infectious Diseases 2020 Abstract

7  Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016. Kamilla Laut, M.D, Ph.D; Andrea Antinori; Barbara Bartmeyer; Marek Beniowski; Fabrice Bonnet; Johanna Brännström; Jordi Casabona; Antonella Castagna; Genevieve Chene; Dominique Costagliola; Antonella d'Arminio Monforte; Julia del Amo; Stephane De Wit; Gerd Faetkenheuer; Hansjakob Furrer; Jacek Gasiorowski; Corinne Jadand; Ole Kirk; Mario K Lazanas; Ignacio Suarez-Lozano; Jens Lundgren; Julia Mikhalik; Amanda Mocroft; Santiago Moreno; Cristina Mussini; Niels Obel; Dzimitry Paduta; Dorthe Raben; Peter Reiss; Andrew Riordan; Caroline A Sabin; Jelena Smidt; Carlo Torti; Tatiana Trofimova; Anna Vassilenko; Marta Vasylyev; Josiane Warszawski; Linda Wittkop; Alexei Yakovlev; Robert Zangerle.
BMC Infect Dis. 2020 7;20(1):728. Abstract

8 What do the changing patterns of comorbidity burden in people living with HIV mean for long‐term management? Perspectives from European HIV cohorts A d'Arminio Monforte, F Bonnet, HC Bucher, V Pourcher, N Pantazis, A Pelchen‐Matthews, G Touloumi , E Wolf
HIV Med. 2020. Abstract

9 A new health care index predicts short term mortality for TB and HIV co-infected people. Roen AO, Podlekareva D, Miller RF, Mocroft A, Panteleev A, Skrahina A, Miro JM, Cayla JA, Tetradov S, Derisova E, Furrer H, Losso MH, Vassilenko A, Girardi E, Lundgren JD, Post FA, Kirk O.
Int J Tuberc Lung Dis. 2020;24(9):956-962. Abstract

10 Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE. Atkinson A, Zwahlen M, Barger D, d'Arminio Monforte A, De Wit S, Ghosn J, Girardi E, Svedhem-Johansson V, Morlat P, Mussini C, Noguera-Julian A, Stephan C, Touloumi G, Kirk O, Mocroft A, Reiss P, Miro JM, Carpenter JR, Furrer H; Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
Clin Infect Dis. 2020:ciaa615. Abstract

11 Healthcare delivery for HIV-positive people with tuberculosis in Europe. Bentzon AK, Panteleev A, Mitsura V, Borodulina E, Skrahina A, Denisova E, Tetradov S, Podlasin R, Riekstina V, Kancauskiene Z, Paduto D, Mocroft A, Trofimova T, Miller R, Post F, Grezesczuk A, Lundgren JD, Inglot M, Podlekareva D, Bolokadze N, Kirk O; TB:HIV Study Group.
HIV Med. 2020. Epub ahead of print. Abstract

12 The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study. Ryom L, Lundgren JD, Reiss P, Ross M, Kirk O, Fux CA, Morlat P, Fontas E, Smith C, De Wit S, d'Arminio Monforte A, El Sadr W, Hatleberg C, Phillips A, Sabin C, Law M, Mocroft A; D:A:D Study Group.
J Infect Dis. 2020:jiaa396. Epub ahead of print. Abstract

13 The relationship between smoking, current CD4, viral load and cancer in persons living with HIV. Mocroft, A, and RESPOND study group.
AIDS. 2020. Epub ahead of print. Abstract

14 Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV. Greenberg L, Ryom L, Neesgaard B, Wandeler G, Staub T, Gisinger M, Skoll M, Günthard HF, Scherrer A, Mussini C, Smith C, Johnson M, De Wit S, Necsoi C, Pradier C, Wit F, Lehmann C, d'Arminio Monforte A, Miró JM, Castagna A, Spagnuolo V, Sönnerborg A, Law M, Hutchinson J, Chkhartishvili N, Bolokadze N, Wasmuth JC, Stephan C, Vannappagari V, Rogatto F, Llibre JM, Duvivier C, Hoy J, Bloch M, Bucher HC, Calmy A, Volny Anne A, Pelchen-Matthews A, Lundgren JD, Peters L, Bansi-Matharu L, Mocroft A; RESPOND study group.
Clin Infect Dis. 2020. Abstract

15 Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.  
Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Huldrych F Günthard, Coca Necsoi, Matthew Law, Cristina Mussini, Antonella Castagna, Antonella d'Arminio Monforte, Christian Pradier, Nikoloz Chkhartisvilli, Juliana Reyes-Uruena, Jörg Janne Vehreschild, Jan-Christian Wasmuth, Anders Sönnerborg, Christoph Stephan, Lauren Greenberg, Josep M Llibre, Alain Volny-Anne, Lars Peters, Annegret Pelchen-Matthews, Vani Vannappagari, Joel Gallant, Armin Rieger, Mike Youle, Dominique Braun, Stephane De Wit, Kathy Petoumenos, Vanni Borghi, Vincenzo Spagnuolo, Tengiz Tsertsvadze, Jens Lundgren, Lene Ryom, RESPOND study group 
PLoS One . 2020;15(12):e0243625.  Abstract

16 Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study. Amele S, Peters L, Rodger A, Lundgren J, Rockstroh J, Matulionyte R, Leen C, Jabłonowska E, Østergaard L, Bhagani S, Sarcletti M, Clarke A, Falconer K, Wandeler G, Domingo P, Maltez F, Zaccarelli M, Chkhartisvili N, Szlavik J, Stephan C, Fonquernie L, Aho I, Mocroft A.
J Acquir Immune Defic Syndr. 2020. Epub ahead of print. Abstract

17 Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study. Petoumenos K, Kuwanda L, Ryom L, Mocroft A, Reiss P, De Wit S, Pradier C, Phillips A, Hatleberg CI, d'Arminio Monforte A, Weber R, Sabin CA, Lundgren J, Law MG; D:A:D Study group.
J Acquir Immune Defic Syndr. 2020. Abstract


Total publications December 2020: 311

​IN PRESS

1 Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with HIV in a European Cohort 
JAIDS.

2 Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
AIDS